Last update 29 Nov 2025

MART-1 antigen(EORTC)

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms-
Target
melan-A
Action
modulators
Mechanism
melan-A modulators(Melanoma antigen recognized by T-cells 1 modulators)
Therapeutic Areas
NeoplasmsEye DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication-
Inactive Indication
Uveal Melanoma
Originator Organization
European Organisation for Research & Treatment of CancerEuropean Organisation for Research & Treatment of Cancer
Active Organization-
Inactive Organization
European Organisation for Research & Treatment of CancerEuropean Organisation for Research & Treatment of Cancer
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MART-1 antigen(EORTC)
NCT00036816
/ TerminatedPhase 3IIT
Randomized Phase III Study Of Adjuvant Immunization With The NA17.A2 And Melanoma Differentiation Peptites In HLA-A2 Patients With Primary Ocular Melanoma At High Risk Of Relapse
100 Clinical Results associated with MART-1 antigen(EORTC)
Login to view more data
100 Translational Medicine associated with MART-1 antigen(EORTC)
Login to view more data
100 Patents (Medical) associated with MART-1 antigen(EORTC)
Login to view more data
100 Deals associated with MART-1 antigen(EORTC)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Uveal MelanomaPhase 3
Belgium
European Organisation for Research & Treatment of CancerEuropean Organisation for Research & Treatment of Cancer
01 Feb 2002
Uveal MelanomaPhase 3
Denmark
European Organisation for Research & Treatment of CancerEuropean Organisation for Research & Treatment of Cancer
01 Feb 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free